Basis: FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the P/B ratio high or low?
The P/B ratio of 7.37 is 22% above its estimated 1-year average of 6.05, near the high end of its estimated 1-year range (5.21–7.37).
As of 2026-10-06T18:30:22.648Z.
Calculation as of: 2026-10-06T18:30:22.648Z.
Quote observation: 2026-10-06T18:30:06.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 026981202cadb8e73b6cbd63f18abfa8ffa74fea80ac6bbb32512047e0825b9f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PB RATIO
7.37
PB RATIO AVG TTM
N/A
PB RATIO AVG 3Y
N/A
PB RATIO AVG 5Y
N/A
PB RATIO AVG 10Y
N/A
PB RATIO AVG 15Y
N/A
PB RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.38
median of 761 covered companies
CURRENT VS SECTOR MEDIAN
+209.66%
vs the sector median at left
Market Cap
$2.29B
PB Ratio
2.29
TTM Avg
2.27
3Y Avg
3.00
5Y Avg
6.05
Market Cap
$2.24B
PB Ratio
10.94
TTM Avg
3.04
3Y Avg
2.28
5Y Avg
4.60
Market Cap
$2.40B
PB Ratio
2.62
TTM Avg
1.86
3Y Avg
2.96
5Y Avg
3.22
Market Cap
$2.40B
PB Ratio
6.38
TTM Avg
4.95
3Y Avg
4.02
5Y Avg
3.47
| NAME | MARKET CAP | PB RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alamar Biosciences, Inc. (ALMR) | $2.31B | 7.37 | N/A | N/A | N/A |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.29B | 2.29 | 2.27 | 3.00 | 6.05 |
| UFP Technologies, Inc. (UFPT)vs › | $2.33B | 5.04 | 4.36 | 5.37 | 4.69 |
| Liquidia Corporation (LQDA)vs › | $2.34B | 11.98 | 93.90 | 47.69 | 30.42 |
| Nurix Therapeutics, Inc. (NRIX)vs › | $2.34B | 5.81 | 4.32 | 3.48 | 2.96 |
| ADMA Biologics, Inc. (ADMA)vs › | $2.37B | 5.80 | 7.24 | 11.83 | 8.79 |
| Maravai LifeSciences Holdings, Inc. (MRVI)vs › | $2.24B | 10.94 | 3.04 | 2.28 | 4.60 |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.40B | 2.62 | 1.86 | 2.96 | 3.22 |
| Clover Health Investments, Corp. (CLOV)vs › | $2.40B | 6.38 | 4.95 | 4.02 | 3.47 |
| Disc Medicine, Inc. (IRON)vs › | $2.41B | 3.75 | 4.33 | 3.62 | 2.68 |
At 7.37, P/B is above its estimated 1-year median — higher than 100% of readings in its estimated 1-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 1-year low
5.21
median
6.13
estimated 1-year high
7.15
P/B Ratio
7.37
Market Price / Book Value per Share
PB Ratio = Market Cap / (Total Shareholders' Equity − Preferred Stock)
The price-to-book ratio compares market capitalization to book value attributable to common shareholders (total equity minus preferred stock). Lower values can indicate a cheaper valuation relative to net assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PB RATIO |
|---|---|
| 2026-10-05 | 7.15 |
| 2026-10-02 | 6.44 |
| 2026-10-01 | 6.09 |
| 2026-09-30 | 6.39 |
| 2026-09-29 | 6.12 |
| 2026-09-28 | 6.11 |
| 2026-09-25 | 6.15 |
| 2026-09-24 | 6.23 |
| 2026-09-23 | 6.03 |
| 2026-09-22 | 6.23 |
| 2026-09-21 | 6.57 |
| 2026-09-18 | 6.53 |
| 2026-09-17 | 6.00 |
| 2026-09-16 | 5.51 |
| 2026-09-15 | 5.39 |
| 2026-09-14 | 5.25 |
| 2026-09-11 | 5.23 |
| 2026-09-10 | 5.21 |
| 2026-09-09 | 5.43 |
| 2026-09-08 | 5.62 |
| 2026-09-04 | 5.78 |
| 2026-09-03 | 5.73 |
| 2026-09-02 | 5.72 |
| 2026-09-01 | 5.51 |
| 2026-08-31 | 5.73 |
| 2026-08-28 | 5.76 |
| 2026-08-27 | 6.19 |
| 2026-08-26 | 6.39 |
| 2026-08-25 | 6.19 |
| 2026-08-24 | 6.13 |
| 2026-08-21 | 6.42 |
| 2026-08-20 | 6.50 |
| 2026-08-19 | 6.66 |
| 2026-08-18 | 6.18 |
| 2026-08-17 | 6.02 |
| 2026-08-14 | 6.22 |
| 2026-08-13 | 6.17 |
| 2026-08-12 | 6.21 |
| 2026-08-11 | 6.86 |
